conivaptan has been researched along with pituitrin in 32 studies
| Studies (conivaptan) | Trials (conivaptan) | Recent Studies (post-2010) (conivaptan) | Studies (pituitrin) | Trials (pituitrin) | Recent Studies (post-2010) (pituitrin) |
|---|---|---|---|---|---|
| 188 | 17 | 64 | 22,137 | 594 | 2,101 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (12.50) | 18.2507 |
| 2000's | 18 (56.25) | 29.6817 |
| 2010's | 9 (28.13) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, N; Kusayama, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T | 1 |
| Ishii, N; Kusayama, T; Saito, M; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T | 1 |
| Burrell, LM; Johnston, CI; Naitoh, M; Risvanis, J | 1 |
| Honda, K; Iizumi, Y; Kusayama, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Wada, K; Yatsu, T | 1 |
| Abe, K; Furuichi, K; Saito, M; Sugimoto, T; Tahara, A | 1 |
| Aoki, M; Arai, Y; Tahara, A; Tomura, Y; Tsukada, J; Wada, K; Yatsu, T | 1 |
| Aoki, M; Arai, Y; Kusayama, T; Tahara, A; Tomura, Y; Tsukada, J; Wada, K; Yatsu, T | 1 |
| Ferguson, JW; Hayes, PC; Newby, DE; Therapondos, G | 1 |
| Ishii, N; Kusayama, T; Shibasaki, M; Suzuki, T; Tahara, A; Taniguchi, N; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T | 1 |
| Doggrell, SA | 1 |
| Greenberg, A; Verbalis, JG | 1 |
| Gross, P; Quittnat, F | 1 |
| Kamyar, M; Lemmens-Gruber, R | 1 |
| Gross, P; Herbrig, K; Palm, C; Pistrosch, F | 1 |
| Lien, YH; Shapiro, JI | 1 |
| Kumar, S; Mather, PJ; Rubin, S; Whellan, DJ | 1 |
| Hobbs, RE; Tang, WH | 1 |
| Laczi, F | 1 |
| Chini, B; Durroux, T; Guillon, G; Manning, M; Mouillac, B; Stoev, S | 1 |
| Barve, A; Elkayam, U; Goldsmith, SR; Haught, WH; He, W | 1 |
| Filippatos, G; Parissis, JT | 1 |
| Elhassan, E; Masoumi, A; Schrier, RW | 1 |
| Dhalla, NS; Rehsia, NS | 1 |
| Reilly, T; Schork, MR | 1 |
| Singh, M; Slawsky, MT; Valania, G | 1 |
| Villabona, C | 1 |
| Hix, J; Sterns, R | 1 |
| Bianzina, S; Dal Canton, A; Esposito, P; Malul, Y; Piotti, G | 1 |
| Balaguru, D; Bricker, JT; Haque, I; Pham-Peyton, C; Sahu, R; Thapar, V | 1 |
| Buehrer, BA; Cassell, MD; Davis, DR; Grobe, JL; Hilzendeger, AM; Ketsawatsomkron, P; Li, H; Littlejohn, NK; Liu, X; Pearson, NA; Pelham, CJ; Siel, RB; Sigmund, CD; Thompson, AP; Weidemann, BJ | 1 |
| Adams, KF; Lin, TE; Patterson, JH | 1 |
| Colwell, CS; Han, HC; Hong, EH; Jin, X; Jung, WW; Kang, HK; Kim, YB; Kim, YI; Kim, YS; Lee, SW; Min, SS | 1 |
17 review(s) available for conivaptan and pituitrin
| Article | Year |
|---|---|
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Diuretics; Heart Failure; Homeostasis; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Animal; Morpholines; Piperidines; Pyrroles; Quinolones; Rats; Spiro Compounds; Vasopressins | 2003 |
Vasopressin receptor antagonists.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Clinical Trials as Topic; Diabetes Insipidus, Nephrogenic; Fibrosis; Heart Failure; Humans; Hyponatremia; Osmolar Concentration; Polycystic Kidney Diseases; Pyrroles; Receptors, Vasopressin; Sodium; Tolvaptan; United States; United States Food and Drug Administration; Vasopressins | 2006 |
Vaptans and the treatment of water-retaining disorders.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Tolvaptan; Vasopressins; Water | 2006 |
Vasopressin antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Binding Sites; Cardiovascular Diseases; Clinical Trials as Topic; Hormone Antagonists; Humans; Indoles; Pyrroles; Pyrrolidines; Tolvaptan; Vasopressins; Water-Electrolyte Imbalance | 2006 |
Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Spiro Compounds; Tolvaptan; Vasopressins | 2006 |
Hyponatremia: clinical diagnosis and management.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney; Kidney Concentrating Ability; Kidney Tubules, Collecting; Male; Osmolar Concentration; Vasopressins | 2007 |
Hyponatremia and vasopressin antagonism in congestive heart failure.
Topics: Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Chronic Disease; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Hyponatremia; Models, Biological; Pyrroles; Registries; Renin-Angiotensin System; Sodium; Tolvaptan; Treatment Outcome; Vasopressins | 2007 |
Vasopressin receptor antagonists in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Pyrroles; Receptors, Vasopressin; Tolvaptan; Vasopressins | 2006 |
[Etiology, diagnostics and therapy of hyponatremias].
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Blood Volume; Brain Diseases; Central Nervous System; Chronic Disease; Demeclocycline; Demyelinating Diseases; Diagnosis, Differential; Diuretics; Extracellular Fluid; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium Compounds; Morpholines; Osmolar Concentration; Osmosis; Pyrroles; Severity of Illness Index; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Vasopressins | 2008 |
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
Topics: Animals; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Deamino Arginine Vasopressin; Female; Humans; Hyponatremia; Lypressin; Oligopeptides; Oxytocin; Peptides; Rats; Receptors, Oxytocin; Receptors, Vasopressin; Structure-Activity Relationship; Terlipressin; Uterus; Vasodilator Agents; Vasopressins | 2008 |
Role of vasopressin and vasopressin receptor antagonists in type I cardiorenal syndrome.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Failure; Humans; Hyponatremia; Kidney; Kidney Diseases; Vasopressins | 2009 |
Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure.
Topics: Angiotensin II; Animals; Antidiuretic Agents; Antihypertensive Agents; Benzazepines; Biomarkers; Bosentan; Catecholamines; Drug Therapy, Combination; Endothelin-1; Heart Failure; Humans; Peptides, Cyclic; Renin-Angiotensin System; Sulfonamides; Sympathetic Nervous System; Tolvaptan; Treatment Outcome; Vasopressins | 2010 |
Vasopressin antagonists: Pharmacotherapy for the treatment of heart failure.
Topics: Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Neurotransmitter Agents; Pyrroles; Tolvaptan; Vasopressins | 2010 |
Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?
Topics: Acute Disease; Animals; Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Hyponatremia; Prognosis; Pyrroles; Tolvaptan; Vasoconstriction; Vasopressins | 2011 |
[Vasopressin receptor antagonists: the vaptans].
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins | 2010 |
The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options.
Topics: Animals; Benzazepines; Disease Management; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neurophysins; Protein Precursors; Vasopressins; Water-Electrolyte Balance | 2011 |
Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Heart Failure; Humans; Hyponatremia; Prospective Studies; Tolvaptan; Vasopressins | 2014 |
1 trial(s) available for conivaptan and pituitrin
| Article | Year |
|---|---|
Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot study.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; Benzazepines; Disease Progression; Diuresis; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Pain Measurement; Pilot Projects; Receptors, Vasopressin; Vasopressins | 2008 |
14 other study(ies) available for conivaptan and pituitrin
| Article | Year |
|---|---|
Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced hyperplasia and hypertrophy of cultured vascular smooth-muscle cells.
Topics: Animals; Benzazepines; Binding, Competitive; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cell Culture Techniques; DNA; Enzyme Activation; Hyperplasia; Hypertrophy; Muscle, Smooth, Vascular; Protein Biosynthesis; Rats; Receptors, Vasopressin; Vasopressins | 1997 |
Vasopressin increases vascular endothelial growth factor secretion from human vascular smooth muscle cells.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cell Line; Dose-Response Relationship, Drug; Endothelial Growth Factors; Humans; Indoles; Lymphokines; Morpholines; Muscle, Smooth, Vascular; Pyrrolidines; Spiro Compounds; Time Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasoconstrictor Agents; Vasopressins | 1999 |
In vivo and in vitro characterisation of a nonpeptide vasopressin V(1A) and V(2) receptor antagonist (YM087) in the rat.
Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Binding, Competitive; Blood Pressure; Dose-Response Relationship, Drug; Iodine Radioisotopes; Kidney; Kinetics; Liver; Male; Membranes; Radioligand Assay; Rats; Rats, Sprague-Dawley; Sodium; Systole; Urination; Vasopressins | 1999 |
[Pharmacology of conivaptan hydrochloride (YM087), a novel vasopressin V1A/V2 receptor antagonist].
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Calcium; Cyclic AMP; Dogs; Female; Heart Failure; Humans; Hyponatremia; In Vitro Techniques; Male; Radioligand Assay; Rats; Vasopressins | 1999 |
Evidence that atypical vasopressin V(2) receptor in inner medulla of kidney is V(1B) receptor.
Topics: Animals; Benzazepines; Calcium; CHO Cells; Cricetinae; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Humans; Indoles; Inositol Phosphates; Kidney Medulla; Morpholines; Pyrrolidines; Rats; Receptors, Vasopressin; Renal Agents; RNA, Messenger; Spiro Compounds; Vasopressins | 2000 |
Effect of the vasopressin receptor antagonist conivaptan in rats with heart failure following myocardial infarction.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Male; Myocardial Infarction; Rats; Rats, Wistar; Vasopressins | 2002 |
Effect of conivaptan, a combined vasopressin V(1a) and V(2) receptor antagonist, on vasopressin-induced cardiac and haemodynamic changes in anaesthetised dogs.
Topics: Anesthesia; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiac Output; Dogs; Dose-Response Relationship, Drug; Female; Hemodynamics; Infusions, Intravenous; Male; Vasopressins | 2002 |
Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Female; Humans; Piperidines; Protein Binding; Receptors, Oxytocin; Receptors, Vasopressin; Second Messenger Systems; Vasopressins | 2005 |
Conivaptan Yamanouchi.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Diuretics; Edema; Heart Failure; Humans; Hyponatremia; Molecular Structure; Structure-Activity Relationship; Vasopressins | 2005 |
Vasopressin antagonists for the treatment of acute decompensated heart failure: when, for whom, for how long, and on what standard therapy?
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuresis; Heart Failure; Humans; Receptors, Vasopressin; Vasopressins | 2008 |
Hyponatremia: vasopressin antagonists in hyponatremia: more data needed.
Topics: Benzazepines; Clinical Trials as Topic; Drug Resistance; Humans; Hyponatremia; Tolvaptan; Vasopressins | 2011 |
Conivaptan therapy in an infant with severe hyponatremia and congestive heart failure.
Topics: Benzazepines; Female; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Infant; Neurophysins; Protein Precursors; Severity of Illness Index; Treatment Outcome; Vasopressins | 2012 |
Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Brain; Gene Expression; Hypertension; Hypothalamus; Mice; Mice, Transgenic; Receptors, Vasopressin; Renin-Angiotensin System; Tolvaptan; Vasopressins | 2013 |
Excessive maternal salt intake gives rise to vasopressin-dependent salt sensitivity of blood pressure in male offspring.
Topics: Animals; Benzazepines; Blood Pressure; Female; gamma-Aminobutyric Acid; Lactation; Male; Neurons; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Receptors, GABA; Sodium; Sodium Chloride, Dietary; Sympathetic Nervous System; Systole; Vasopressins | 2021 |